Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2022 May Editor's pick RELEVANT LITERATURE FOR YOUR DAILY PRACTICE SELECTED BY: JAN PHILIPPÉ Read more
2022 May Clinical trials Outcomes in adolescent and young adult patients compared to younger patients treated for high-... Read more
2022 May Prevention Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ... Read more
2022 May Clinical practice 2021 Update on measurable residual disease in acute myeloid leukaemia Read more
2022 May Science Flow cytometric MRD assessment in B-cell precursor ALL patients treated with CD19-targeted the... Read more
Top
